Study details
Enrolling now
Anti-Inflammatory Drugs and Prostate-Specific Antigen Test
Albany Medical College
NCT IDNCT05629494ClinicalTrials.gov data as of Apr 2026
Phase
Phase 4
Target enrollment
198
Study length
about 4.2 years
Ages
18–80
Sex
Male only
Locations
3 sites in IL, NY, PA
About this study
Researchers are testing whether taking ibuprofen, a common anti-inflammatory drug, can lower PSA levels in men with elevated PSA. The trial will involve approximately 200 adult men who have an elevated PSA level. Participants will take ibuprofen three times daily for about 15 months.
Based on ClinicalTrials.gov records.
What participants do
- 1.PSA test
- 2.Take Ibuprofen 400 mg, TID
PhasePhase 4
DrugIbuprofen 400 mg, TID
Routeoral
Participation effort
Estimated from trial records. Details can vary by site.
Time + visits
Low12%
Logistics
Moderate50%
Logistics difficulty varies by site location and availability.
Trial highlights
Treatment details
Auto-extracted from trial records to preview treatments and outcomes.
Drug classes
ibuprofen
Drug routes
oral
Endpoints
Secondary: Changes in voiding symptoms as measured by the International Prostate Symptom Score
Procedures
diagnostic
Body systems
Reproductive Health, Oncology